Musculoskeletal Quantitative Imaging Research, Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.
Ann N Y Acad Sci. 2011 Dec;1240:77-87. doi: 10.1111/j.1749-6632.2011.06282.x.
The noninvasive quantification of peripheral compartment-specific bone microarchitecture is feasible with high-resolution peripheral quantitative computed tomography (HR-pQCT) and high-resolution magnetic resonance imaging (HR-MRI). In addition to classic morphometric indices, both techniques provide a suitable basis for virtual biomechanical testing using finite element (FE) analyses. Methodical limitations, morphometric parameter definition, and motion artifacts have to be considered to achieve optimal data interpretation from imaging studies. With increasing availability of in vivo high-resolution bone imaging techniques, special emphasis should be put on quality control including multicenter, cross-site validations. Importantly, conclusions from interventional studies investigating the effects of antiosteoporotic drugs on bone microarchitecture should be drawn with care, ideally involving imaging scientists, translational researchers, and clinicians.
高分辨率外周定量计算机断层扫描(HR-pQCT)和高分辨率磁共振成像(HR-MRI)可实现外周隔室特异性骨微观结构的无创定量。除了经典的形态计量学指标外,这两种技术都为使用有限元(FE)分析进行虚拟生物力学测试提供了合适的基础。为了从影像学研究中获得最佳的数据解释,必须考虑方法学限制、形态计量参数定义和运动伪影。随着体内高分辨率骨成像技术的日益普及,应特别重视质量控制,包括多中心、跨站点验证。重要的是,应谨慎得出研究抗骨质疏松药物对骨微观结构影响的干预性研究的结论,最好让影像学科学家、转化研究人员和临床医生参与进来。